NCT02043912View on ClinicalTrials.gov

Drug Interactions With Risk of QT-prolongation in a General Hospital

CompletedOBSERVATIONAL
Enrollment

222

Participants

Timeline

Start Date

July 31, 2013

Primary Completion Date

February 28, 2014

Study Completion Date

April 30, 2014

Conditions
QT-prolongation
Interventions
DRUG

Haloperidol

Trial Locations (1)

3000

Universitair Ziekenhuis Leuven, Leuven

All Listed Sponsors
collaborator

Agentschap voor Innovatie door Wetenschap en Technologie

OTHER

lead

KU Leuven

OTHER

NCT02043912 - Drug Interactions With Risk of QT-prolongation in a General Hospital | Biotech Hunter | Biotech Hunter